The complexity and diversity of cancer types require continuous development of new treatments. As cancer cells evolve, they may develop resistance to existing therapies, necessitating the creation of more effective and targeted options. Moreover, there is an increasing need to minimize side effects and improve the quality of life for patients undergoing treatment.
